The Standard & Poor’s Dividend Aristocrats represent the crème de la crème of dividend growth stocks. These are all companies that have increased their dividend for a minimum of 25 consecutive years. Many of them have consecutively increased their dividends for 30 years, 40 years, 50 years or more. Therefore, they offer a level of predictable dividend growth that is unsurpassed by any other dividend paying stocks.
From a quality perspective, all the Standard & Poor’s Dividend Aristocrats are awarded investment grade credit ratings. Six of the 68 Dividend Aristocrats are BBB- to BBB+ and all the rest are rated A- or better. Consequently, these high-quality dividend growth stocks represent the best-of-breed dividend growers for prudent investors focused on dividend growth to invest in. However, and unfortunately, in today’s low interest rate environment, most of these best-of-breed dividend growth stocks have become overvalued in the marketplace. Therefore, investors need to consider, recognize, and even acknowledge that even the best of stocks can become overvalued and therefore poor long-term investment candidates.
With this video I will cover 18 examples of my favorite businesses that I believe have become un-investable due to extremely high valuations. In this video I will be analyzing these stocks through the lens of FAST Graphs: Automatic Data Processing (ADP), Albemarle (ALB), Air Products (APD), Colgate Palmolive (CL), Clorox (CLX), Cintas (CTAS), Ecolab (ECL), Emerson Electric (EMR), Hormel Foods (HRL), Illinois Tool Works (ITW), Coca Cola (KO), McDonalds (MCD), Medtronic (MDT), McCormick (MKC), Procter & Gamble (PG), Roper (ROP), Sherwin Williams (SHW), S&P Global (SPGI)
FAST Graphs Analyze Out Loud Video:
Disclosure: Long MDT.
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.